Announcement on Voluntary Disclosure of the Progress in Phase I Clinical Trial for Innovative Drug SGC001 of the Joint-Stock Company
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment